Nuclear imaging for prostate cancer: What’s new?

Slides:



Advertisements
Similar presentations
CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS
Advertisements

Nuclear Medicine. Nuclear Medicine Physiological Imaging Radioactive isotopes which emit gamma rays or other ionizing forms (half life for most is hours.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Radioisotopes in Medicine
The Bone Scan By Lance Lewis An Illustration of a Bone Scan Taking Place.
Nuclear Medicine By: Amanda Taulanga 3B.
PET/CT & PET/MRI Radiopharmacy
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
Medical Imaging Technology
MEDICAL IMAGING.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Positron Emission Tomography (PET)
HYBRID IMAGING.  Combination  Nuclear medicine  Radiology  PET/CT  Positron emission tomography  Computed tomography  SPECT/CT  Single photon.
radio-iodinated metaiodobenzylguanidine (123I-MIBG)
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
Diagnostic Testing  Diagnostic tests provide information about the structure and function of organs, tissues, and cells.  Medical imaging produces images.
Follow up in Chest Tumors : Value of integrated PET/CT By : Dr. Heba Nabil, MSc Radiology Specialist at Nasser Institute For Research and Treatment.
INNA GERTSENSHTEYN MARCH 24, 2014 Endoscopic TOFPET (Time of Flight Positron Emission Tomography) & Ultrasound Working with: Giacomo Cucciati and Marco.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
December Rontgen’s wife’s hand. The first Xray.
NeoTect Tc99m Depreotide Injection. NeoTect  Approved by the FDA - August 3, 1999  Used in Imaging Pulmonary Masses  Normal activity in high concentrations.
DETECTING LUNG AND BREAST CANCER BY RAVEN, JENAYA, SHARIA, ISAAC AND AMAN.
Medical Imaging Technologies Medical imaging produces images of organs and tissues within the body for use in diagnosis and treatment.
1 By Maribel Aguilar. 2 What is Gallium Scan?  Type of nuclear medicine that uses radioactive tracers.  Radioactive tracers common use in gallium scan.
Molecular Imaging & Positron Emission Tomography Nicholas Mulhern BME 281.
NUCLEAR MEDICINE.  High Energy Photon  Ionizing Radiation --Radiopharmaceutical  Exposes Detector  Projection Data  Dynamic / Physiologic Here we.
Introduction to NM Omima Adam NMT 231. What is nuclear medicine NM Is the branch of medicine that uses radiation and nuclear properties of radionuclide's.
PET/MR in Oncology: Non– 18 F- FDG Tracers for Routine Applications R2 丁建鑫.
Nuclear Medicine and PET rev this is now slide 1do not print it to pdf things to do (check off when complete): add revision date to cover page.
Nuclear Medicine Physics and Equipment 243 RAD 1 Dr. Abdo Mansour Assistant Professor of radiology
Introduction to Medical Imaging SPECT, Introduction to Medical Imaging SPECT, PET and Lesion Detection Guy Gilboa Course
Radioisotopes Gallium-67.
Positron Emission Tomography.
 Two reasons medical tracers can be placed in a body:  Diagnose disease or Treat Disease  In both cases, several factors must be accounted for:  Gamma.
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Detection of Bone Cancer with the use of radioisotope Fluorine 18 in Medicine Andrea Kozera.
Molecular Imaging “101” The Role of Molecular Imaging in Cancer Briefing and Roundtable Washington, DC July 22, 2008 Martin G. Pomper, MD, PhD Russell.
Radiological Procedures By: Tori Melerine. CT Scans.
Choline PET/CT Robert S. Bridwell MD MBA Founder and CMO Appian 360
5.5 Medical Applications Using Radioactivity
Medical Imaging.
Using PET/CT in Prostate Cancer
This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in.
Using PET/CT in Prostate Cancer
Klinikum rechts der Isar, Technische Universität München
P.E.T. Positron Emission Tomography
Medical Imaging Illuminating the Body.
PET Applications in Oncology 2015/2016
Organization of the lecture
Learning Objectives By the end of this lesson you should…
Overview of Nuclear Technologies in Healthcare
Methods and Tools for Studying the Brain
Radiation in Medicine.
Chain Reactions Chain Reaction - the series of repeated fission reactions caused by the release of neutrons in each reaction.
3.1 Medical Imaging Technology
Tc99m Depreotide Injection
Jaden D. Evans, MD, Krishan R
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.
Radioisotopes in Medicine
Updates in Detection and Management of BCRPC
Positron Emission tomography
Function and Structure in
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer 
POSITRON EMISSION TOMOGRAPHY
Nuclear Medicine Technologies
(A) Na18F PET images (maximum-intensity projection).
Fig. 1.Representative images of 18F-FDG PET-CT and immunohistochemical staining for TILs. (A) Whole-body 18F-FDG PET image demonstrates increased FDG uptake.
Presentation transcript:

Nuclear imaging for prostate cancer: What’s new? Dr. Debra Freeman July 25, 2017

Disclosures Employed by CyberKnife Centers of Tampa Bay Active board member of the CyberKnife Coalition (CKC) Co-director of the Registry for Prostate Cancer Radiosurgery

The basics of nuclear imaging A radioisotope is attached to an inert molecule to create a radiotracer Step 1 Radiotracer is injected into the patient Gamma rays are emitted as the radiotracer decays Step 2 Emissions are measured using a gamma detector Measurements are summed and reformatted to create visible images Step 3

Hospitals generally use two types of gamma emission detectors: Single photon emission scanner (SPECT) Positron emission tomography scanner (PET/CT)

SPE(CT) scans

Standard whole body bone scan Technetium-99 (radioisotope) is attached to methylene disphosphonate (inert molecule) to create the radiotracer Radiotracer is injected and taken up at sites of bone rebuilding (osteoblastic) activity Images are acquired using 2-D gamma camera or 3-D SPECT scanner 78-80% sensitivity for detection of bone metastases from prostate cancer

Normal scan Bone metastases

ProstaScint scan Indium-11 (radioisotope) attached to prostate specific membrane antigen (PSMA)-a prostate cell surface protein Radiotracer is absorbed primarily in soft tissues Overall accuracy of approx. 68% for detection of recurrent disease Better if fused with CT or MRI scans

ProstaScint scan CT scan Fused study

PET/CT scans

F-18 FDG-PET Fluorine-18 (radioisotope) is attached to 2-deoxy-2-fluoro-D-glucose to create radiotracer Actively dividing cells, like cancer cells, take up more glucose than normal cells False positive results: inflammation infection False negative results: slow growing tumors* small lesions (<5mm) hyperglycemia

FDG-PET for prostate cancer Limited use for detection and initial staging of primary prostate cancer More useful for detection of aggressive disease, evaluation of metastatic disease and response to therapy

18-F NaF PET bone scan Fluorine-18 (radioisotope) attached to sodium fluoride to create the radiotracer 18-F NaF is a highly sensitive radiotracer for skeletal metastases Emission data acquired with positron emission tomography (same detector as FDG-PET) More sensitive than Tc-99 bone scan for early detection of bone metastases

18-F fluciclovine (Axumin) PET scan Fluorine-18 (radioisotope) attached to an amino acid analog of L-leucine, creating the radiotracer (Axumin) Levels of many amino acids are increased within prostate cancer cells, as compared to normal tissues Gamma emissions detected using positron emission tomography (again , same scanner as FDG-PET) Axumin may be superior other radiotracers for detection of recurrent disease in the setting of PSA failure

Other radiotracers being studied for prostate cancer imaging Carbon-11 (radioisotope) attached to choline Carbon-11 attached to acetate (metabolized into acetyl-CoA) F-18 attached to fluoro-dihydrotesterone (FDHT)

The future… PET/MRI fusion scans GE and Siemens already have scanners in production Functional MRI Androgen receptor PET scans